Primary aldosteronism is the most common and curable form of secondary arterial hypertension. We performed wholeexome sequencing in patients with early-onset primary aldosteronism and identified a de novo heterozygous c.71G> A/ p.Gly24Asp mutation in the CLCN2 gene, encoding the voltage-gated ClC-2 chloride channel 1 , in a patient diagnosed at 9 years of age. Patch-clamp analysis of glomerulosa cells of mouse adrenal gland slices showed hyperpolarization-activated Cl -currents that were abolished in Clcn2 −/− mice. The p.Gly24Asp variant, located in a well-conserved 'inactivation domain' 2, 3 , abolished the voltage-and time-dependent gating of ClC-2 and strongly increased Cl -conductance at resting potentials. Expression of ClC-2 Asp24 in adrenocortical cells increased expression of aldosterone synthase and aldosterone production. Our data indicate that CLCN2 mutations cause primary aldosteronism. They highlight the important role of chloride in aldosterone biosynthesis and identify ClC-2 as the foremost chloride conductor of resting glomerulosa cells.
Arterial hypertension is a major cardiovascular risk factor 4 . Primary aldosteronism is the most common and curable form of secondary arterial hypertension, with an estimated prevalence of ~10% in referred patients and 4% in primary care 5 , and a prevalence of up to 20% in patients with resistant hypertension 6 . Primary aldosteronism results from autonomous aldosterone production in the adrenal cortex 7 , caused in most cases by a unilateral aldosterone-producing adenoma or bilateral adrenal hyperplasia (BAH). It is diagnosed on the basis of hypertension associated with an increased aldosteroneto-renin ratio and often hypokalemia 8 . In comparison to essential hypertension, increased aldosterone levels in primary aldosteronism are associated with increased cardiovascular risk, in particular for coronary artery disease, heart failure, renal damage, and stroke 9, 10 . Gain-of-function mutations in different genes, encoding cation channels (KCNJ5 11 , CACNA1D 12, 13 , and CACNA1H 14, 15 ) and ATPases (ATP1A1 and ATP2B3 12, 16 ), regulating intracellular ion homeostasis and plasma membrane potential, have been described in aldosterone-producing adenoma and familial forms of primary aldosteronism, but the pathophysiology of many cases is still unknown.
We performed whole-exome sequencing on germline DNA from 12 patients with young-onset hypertension and hyperaldosteronism diagnosed before 25 years of age. Two index cases were investigated together with their parents and unaffected sibling to search for de novo variants. A de novo germline CLCN2 variant, c.71G> A (NM_004366; p.Gly24Asp), was identified in subject K1011-1, but not in her asymptomatic parents (K1011-3 and K1011-4) and sibling (K1011-2; Fig. 1a ,b and Table 1 ). The variant was absent from more than 120,000 alleles in the Exome Aggregation Consortium (ExAC) database and in our in-house database. We did not find additional CLCN2 variants among the other 11 investigated individuals. CLCN2 encodes the chloride channel ClC-2. The variant p.Gly24Asp is located in its N-terminal cytoplasmic domain (Fig. 1c,d ). Gly24 is highly conserved in ClC-2 from species as distant as zebrafish and Xenopus tropicalis (Fig. 1c) .
The patient carrying the CLCN2 variant encoding p.Gly24Asp is a 9-year-old girl who presented with severe headache and vomiting lasting for 1 year ( Table 1 ). The child was developmentally normal, first born to a non-consanguineous couple. There was a history of mild hypertension in the maternal grandmother and granduncle. Blood pressure was 172/100 mm Hg, and heart rate was 120 beats/min. The rest of the examination was normal. Her work-up showed persistent hypokalemia (serum K + ranging from 1.8 to 2.4 meq/L), elevated serum aldosterone (868.1 pg/ml, reference range 12-340 pg/ml), and suppressed plasma renin activity (0.11 ng/ml/h, reference range 1.9 to 6.0 ng/ml/h in an upright posture), suggestive of primary aldosteronism. Abdominal computed tomography (CT) scans showed no adrenal abnormalities. Other parameters including 24-h urinary vanillylmandelic acid and serum cortisol were normal. Hypertension was initially managed with amlodipin, enalapril, and atenolol. Once the diagnosis of primary aldosteronism was made, spironolactone was added, enalapril was stopped, and the doses of amlodipin and atenolol were reduced. Serum K + normalized. A positive glucocorticoid suppression test (with aldosterone at 949.3 pg/ml at baseline and 56.9 pg/ml after oral administration of 0.5 mg of dexamethasone every 6 h for 48 h) suggested the possibility of glucocorticoid-remediable aldosteronism (GRA), a rare familial Letters NATurE GENETiCs form of hyperaldosteronism 17 . However, genetic analysis for a chimeric CYP11B1-CYP11B2 gene was negative. The child's hypertension has been well controlled over 18 months with prednisolone at 5 mg/m 2 /d, spironolactone, and amlodipin. On treatment, her serum aldosterone and plasma renin levels are 421 pg/ml (reference range 25 to 392 pg/ml) and 8.22 µ U/ml (4.4 to 46.1 µ U/ml), respectively. After exclusion of GRA by genetic testing, prednisolone treatment was stopped.
Cl -conductance can regulate the excitability of neuronal, muscle, and endocrine cells [18] [19] [20] [21] . In zona glomerulosa cells, adrenocorticotropic hormone (ACTH)-activated Cl -currents have been described 22 , but their outward rectification sets them apart from hyperpolarization-activated ClC-2 currents. ClC-2 is expressed in almost all tissues 1 and may have roles in ion homeostasis and transepithelial transport 23 . Clcn2 −/− mice display early postnatal retinal and testicular degeneration 24 as well as leukodystrophy 25, 26 ; in humans, CLCN2 loss-of-function mutations result in leukodystrophy 27 that may be associated with azoospermia 28 . These phenotypes have been ascribed to a role for ClC-2 in extracellular ion homeostasis 24, 25 . Data retrieved from a transcriptome analysis including 11 human adrenal glands 29 showed high expression of CLCN2 in human adrenal cortex (Supplementary Table 1 ). In mice, western blots showed similar expression of ClC-2 in whole adrenal gland as in brain (Fig. 2a) , which expresses substantial, physiologically important amounts of ClC-2 25 . Patch-clamp analysis of glomerulosa cells in situ showed typical hyperpolarization-activated currents in wild-type mice, but not in Clcn2 −/− mice (Fig. 2b,c) . The magnitude of these currents was similar to those observed in Bergmann glia, which prominently express ClC-2 26 . The almost complete absence of Cl -currents in Clcn2 −/− cells demonstrates that under resting conditions ClC-2 mediates the bulk of glomerulosa cell Cl -currents. The ClC-2 p.Gly24Asp variant is located in a highly conserved inactivation domain 2, 3 of the channel. Deletions and point mutations mapping to this region and to an intracellular loop 2 (highlighted in Fig. 1c,d) lead to 'open' ClC-2 channels that have lost their sensitivity to voltage, cell swelling, or external pH 2, 3 . Likewise, insertion of the p.Gly24Asp variant drastically changed voltage-dependent gating of ClC-2 (Fig. 2d,e,h ) and dramatically increased current amplitudes when the human protein was expressed in Xenopus laevis oocytes (Fig. 2d-g ). When measured at -80 mV, the approximate resting potential of glomerulosa cells 30 , current amplitudes from the mutant channel were much larger than those for the wild-type channel ( Fig. 2d-f) . Linear, ohmic currents like those of the mutant channel might be due to unspecific electrical leaks; however, the currents of both wild-type and mutant ClC-2 were markedly reduced when extracellular chloride was replaced by iodide ( Fig. 2d-f ), in agreement with the Cl -> I -selectivity of ClC channels in general 23 and ClC-2 in particular 1 . similarly to the p.Gly24Asp substitution described here. CBS1 and CBS2 are cystathionine-β -synthase domains that can affect gating of ClC channels 23 . . Likewise, the ClC-2 Asp24 mutant had largely reduced pH sensitivity (Fig. 2i,j and Supplementary Fig. 1 ). In conclusion, the p.Gly24Asp variant results in a strong gain of function, in line with the dominant disease phenotype of the mutation that is present in the heterozygous state. It also suggests a pathophysiological mechanism in which a strong increase in (Fig. 3a,b) , aldosterone synthase expression (Fig. 3a,c ) and aldosterone production (Fig. 3d,e) (Fig. 3e) . A further increase was observed in cells expressing ClC-2 Asp24 after Ang II stimulation, but not after K + stimulation (Fig. 3e) . Nevertheless, also after stimulation, aldosterone production in cells expressing ClC-2 Asp24 was significantly higher than in cells expressing ClC-2 WT (Fig. 3e) . Infection of H295R-S2 cells with shRNA constructs targeting ClC-2 reduced CLCN2 expression by ~50% ( Supplementary Fig. 2a ) as compared with a scrambled shRNA and significantly reduced aldosterone production, both at baseline and after stimulation ( Supplementary  Fig. 2b ), suggesting that even ClC-2 WT currents, although much smaller than currents from the ClC-2 Asp24 mutant, increase the excitability of H295R-S2 adrenocortical cells. These changes were paralleled in both models by concomitant modifications of the expression of steroidogenic genes. An increase in the mRNA expression of CYP11B2 (encoding aldosterone synthase; Fig. 3f ), STAR (encoding the steroidogenic acute regulatory protein; Fig. 3g ), and CYP21A2 (encoding steroid 21-hydroxylase; Fig. 3h Clcn2 -currents at -80 mV (I -80 mV ) (g) and current ratios (I -120 mV /I +60 mV ) as a measure of rectification (h) (always measured at 2 s) for panels d-f. ****P < 0.0001, Mann-Whitney two-tailed test. i,j, Effect of external pH on currents mediated by ClC-2 WT (i) and ClC-2 Asp24 (j) in Xenopus oocytes. Currents were normalized to mean currents from the respective construct measured after 2 s at -120 mV and at pH 7.4. The number of oocytes analyzed is given in parentheses; error bars, s.e.m.
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CYP11B2 expression under all conditions ( Supplementary Fig. 2c ). These data further support the notion that a gain-of-function CLCN2 mutation may depolarize the cell, activate the steroidogenic pathway, and increase aldosterone production. While knockdown of ClC-2 influences aldosterone production in H295R-S2 cells, which have a resting potential of about -65 mV (Fig. 4a,b) , this may not be the case in native glomerulosa cells. Because their membrane voltage (V m ) is close to the K + equilibrium potential 30 , they are unlikely to markedly hyperpolarize upon loss of ClC-2. No changes in blood pressure have been reported for mice or patients lacking ClC-2 24, 25, 27 , but this issue has not been investigated in detail. We next explored the effect of the ClC-2 p.Gly24Asp variant on membrane potential and calcium influx through voltage-gated calcium channels. These studies were performed with the perforated . These blots are representative of three independent experiments, with actin serving as a loading control. b, Quantification of ClC-2 protein levels in ClC-2 WT and ClC-2 Asp24 H295R-S2 cells (t test, P = 0.10, F = 3.19). c, Quantification of aldosterone synthase expression in ClC-2 WT and ClC-2 Asp24 H295R-S2 cells (t test, P = 0.0025, F = 136). d, Basal aldosterone production by H295R-S2 cells transfected to express ClC-2 WT or mutant ClC-2 Asp24 (t test, P = 0.0008, F = 142). e, Basal and stimulated aldosterone production by H295R-S2 cells transfected to express WT (open bars) or mutant ClC-2 Asp24 (filled bars) (one-way ANOVA, P < 0.0001, F = 23.46). f-h, Basal and stimulated mRNA expression of CYP11B2 (one-way ANOVA, P < 0.001, F = 18.39) (f), STAR (Kruskal-Wallis, P = 0.0033) (g), and CYP21A2 (one-way ANOVA, P < 0.0001, F = 23.27) (h) in H295R-S2 cells transfected to express WT (open bars) or mutant ClC-2 Asp24 (filled bars). Quantifications of protein expression (using actin as a loading control) and aldosterone production are presented as the percentage of the value for ClC-2 WT -expressing cells under basal conditions, and the results of mRNA expression are presented as fold induction relative to ClC-2 WT -expressing cells under basal conditions. Values of all experiments are presented as the means ± s.e.m. of three independent experiments performed in experimental triplicate (n = 9) for each condition. *P < 0.05; **P < 0.01; ***P < 0.001; i, P < 0.05 for the stimulated versus basal condition; ii, P < 0.01 for the stimulated versus basal condition; iii, P < 0.001 for the stimulated versus basal condition.
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NATurE GENETiCs patch-clamp technique, which does not disturb the intracellular chloride concentration and is required to see the full effect of inactivation domain 2,3 mutations 31, 32 . In the stably transfected H295R-S2 cells used to investigate steroidogenesis (Fig. 3) , there was a trend toward V m being depolarized in ClC-2
Asp24
-as compared to ClC-2 WT -overexpressing cells (mean values of roughly -52 and -67 mV, respectively) (Fig. 4a) . However, because these cell lines were not clonal, the variability was large and the difference was not statistically significant.
We therefore resorted to transient transfection of H295R-S2 cells, which allowed us to select ClC-2-expressing cells by fluorescence of cotransfected GFP (Fig. 4b-g ). Although these cells express ClC-2 less efficiently than Xenopus oocytes (compare Figs. 4f and 2d ) and HEK cells 31, 32 , ClC-2
-expressing cells displayed robust
Cl
-currents that lacked strong voltage dependence ( Fig. 4c-g ). The observed increase in currents may reflect increases in both the currents for individual channels and the number of channels; both must be considered when analyzing the pathogenic effects of ion channel mutants. This increase in currents correlated with a strong depolarization from V m = -69 ± 7 mV in ClC-2 WT -expressing cells to -46 ± 4 mV in ClC-2 Asp24 -expressing cells (Fig. 4b) , indicating that chloride concentration in H295R-S2 cells is higher than predicted from the electrochemical equilibrium. This depolarization may open voltage-dependent calcium channels. Indeed, nifedipine (an L-type calcium channel blocker) and/or mibefradil (a T-type calcium channel blocker) strongly reduced aldosterone production in cells expressing the ClC-2
Asp24 mutant (Fig. 4i) . The involvement of L-type calcium channels appeared to be larger in ClC-2 , -52 ± 6 mV (n = 12)), which, however, was not significant (twotailed Mann-Whitney, P = 0.14) owing to large variability in V m for ClC-2 
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NATurE GENETiCs cells (Fig. 4h) , possibly because of the depolarized plasma membrane potential of these cells, which is required to open L-type calcium channels 33 . However, we cannot exclude the possibility that nifedipine acted partially through T-type calcium channels, which are also blocked by this compound at depolarized voltages 34 .
To investigate whether the CLCN2 mutation encoding p.Gly24Asp could be involved in other forms of primary aldosteronism, we sequenced exon 2 of CLCN2 in 100 patients with BAH. While the CLCN2 mutation encoding p.Gly24Asp was not identified among these subjects, we found two rare CLCN2 variants, c.197G> A (p.Arg66Gln, rs755883734) and c.143C> G (p.Pro48Arg, rs115661422) in two subjects (Supplementary Fig. 3 ). The minor allele frequencies of these variants were very low in the ExAC database (CLCN2 p.Arg66Gln, 0.00003; CLCN2 p.Pro48Arg, 0.0017). Both variants failed to significantly change ClC-2 currents in Xenopus oocytes in which the mutant proteins were heterologously expressed ( Supplementary Fig. 4 ), in spite of a previously described 35 moderate reduction in ClC-2 Arg48 current amplitudes. Nonetheless, it is noteworthy that the two patients were diagnosed with hypertension at a young age, at 29 and 19 years, respectively (Table 1) , and in both cases during pregnancy. Finally, sequencing the CLCN2 exons encoding the N-terminal domain (exons 1 and 2) and the loop between helices J and K (exon 10), corresponding to the ClC-2 inactivation domains 2, 3 , in 20 additional patients with hypertension before 20 years of age did not identify additional mutations. Among these patients, nine had a history of hypertension before the age of 15 years (one before 10 years), indicating that CLCN2 mutations might underlie forms of primary aldosteronism with very young onset.
In conclusion, we show that a gain-of-function mutation affecting the ClC-2 chloride channel underlies a genetic form of secondary arterial hypertension and identify ClC-2 as the foremost chloride conductor of resting glomerulosa cells. We suggest that increased Cl -currents induced by the ClC-2 p.Gly24Asp variant could depolarize the zona glomerulosa cell membrane, thereby opening voltage-gated calcium channels that trigger autonomous aldosterone production by increasing intracellular Ca 2+ concentrations (Fig. 5b, orange arrows) . We hypothesize that the increased Cl -currents may overcome the hyperpolarizing currents of K + channels that normally determine the glomerulosa cell resting potential.
The inhibition of these potassium channels, for example upon Ang II stimulation, or the depolarizing currents mediated by these channels upon increases in extracellular K + are the main mechanisms triggering aldosterone production under physiological conditions (Fig. 5a, dashed black arrows) .
Not only mutations mapping to the N-terminal ClC-2 inactivation domain 2, 3 , like the p.Gly24Asp variant found here, but also those mapping to the cytoplasmic linker between transmembrane helices J and K may cause primary aldosteronism (Fig. 1d) . Several point mutations affecting this linker result in constitutively open ClC-2 channels 2 . We propose both regions as potential hotspots for mutations causing primary aldosteronism. The discovery that a chloride channel is involved in primary aldosteronism opens new and unexpected perspectives for the pathogenesis and treatment of arterial hypertension.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41588-018-0053-8. 8 . In patients diagnosed with primary aldosteronism, a thin-slice CT scan or magnetic resonance imaging (MRI) of the adrenal and/or an adrenal venous sampling (AVS) was performed to differentiate between unilateral and bilateral aldosterone hypersecretion. All patients gave written informed consent for genetic and clinical investigation. Procedures were in accordance with institutional guidelines (Assistance PubliqueHôpitaux de Paris).
DNA isolation. DNA from peripheral blood leukocytes was extracted using the QIAamp DNA midi kit (Qiagen) or salt extraction.
Whole-exome sequencing and variant detection. Exomes were enriched in solution and indexed with SureSelect XT Human All Exon 50 Mb kits (Agilent). Sequencing was performed as 100-bp paired-end runs on HiSeq 2000 systems (Illumina). Pools of 12 indexed libraries were sequenced on four lanes. Image analysis and base calling were performed using Illumina Real Time Analysis. CASAVA 1·8 was used for demultiplexing. BWA (v 0.5.9) with standard parameters was used for read alignment against human genome assembly hg19 (GRCh37). We performed single-nucleotide variant and small insertion and deletion (indel) calling specifically for the regions targeted by the exome enrichment kit, using SAMtools (v 0.1.18). Subsequently, variant quality was determined using the SAMtools varFilter script. We used default parameters, with the exception of the maximum read depth (-D) and the minimum P value for base quality bias (− 2), which we set to 9,999 and 1 × 10 -400
, respectively. Additionally, we applied a custom script to mark all variants with adjacent bases of low median base quality. All variants were then annotated using custom Perl scripts. Software is available on request (see URLs). Annotation included information about known transcripts (UCSC Known Genes and RefSeq genes), known variants (dbSNP v 135), type of mutation, and-if applicable-amino acid change in the corresponding protein.
The annotated variants were then inserted into our in-house database. To reduce false positives, we filtered out variants that were already present in our database, had variant quality less than 40, or failed one of the filters from the filter scripts. We then manually investigated the raw read data of the remaining variants using the Integrative Genomics Viewer (IGV).
Sanger sequencing. CLCN2 DNA was amplified using the intron-spanning primers described in Supplementary Table 2. PCR was performed on 100 ng of DNA in a final volume of 25 µ l containing 0.75 mM MgCl 2 , 400 nM of each primer, 200 µ M deoxynucleotide triphosphate, and 1.25 U Taq DNA Polymerase (Sigma). Cycling conditions for CLCN2 were as previously described 37 with an annealing temperature of 60 °C. Direct sequencing of PCR products was performed using the ABI Prism Big Dye Terminator v3.1 Cycle Sequencing kit (Applied Biosystems) on an ABI Prism 3700 DNA Analyzer (Applied Biosystems).
Site-directed mutagenesis. The ClC-2 Asp24 construct was generated by site-directed mutagenesis using the QuikChange II XL site-directed mutagenesis kit (Agilent). The mutation was introduced into the human ClC-2 cDNA fragment inserted into the pFROG expression vector 38 , and the presence of the mutation was confirmed by Sanger sequencing.
Western blotting. The membrane fractions of tissue homogenate from brain and adrenal glands of adult Clcn2
+/+ and Clcn2 −/− mice were isolated and lysed in 50 mM Tris pH 6.8, 140 mM NaCl, 0.5 mM EDTA, and 2% SDS with protease inhibitors (4 mM Pefabloc and Complete EDTA-free protease inhibitor cocktail, Roche). Equal amounts of protein were separated by SDS-PAGE (10% polyacrylamide) and blotted onto nitrocellulose. Rabbit polyclonal antibodies against a modified C-terminal ClC-2 peptide have been described previously 26 . Blots were reprobed with mouse antibody to β -actin (clone AC-74, Sigma, A2228, 1:1,000) as a loading control.
H295R-S2 cells were lysed using RIPA buffer (Bio Basic Canada) with protease and phosphatase inhibitor mini tablets, EDTA free (Thermo Scientific). Proteins were solubilized for 30 min at 4 °C, under end-over-end rotation, and then centrifuged at 13,000 r.p.m. for 15 min at 4 °C. Equal amounts of protein were subjected to 10% SDS-PAGE and transferred onto nitrocellulose. Membranes were blotted with rabbit antibody to ClC-2 (1:500), mouse antibody to aldosterone synthase (1:500, clone CYP11B2-41-13, kindly provided by C. Gomez-Sanchez, University of Mississippi 39 ), and mouse antibody to β -actin (A2228, 1:10,000, Sigma).
Electrophysiological recordings. Patch-clamp analysis was performed in adrenal sections from wild-type and Clcn2
−/− mice 24 , similarly to previously described experiments 40 . Bicarbonate-based buffers were used, which were continuously bubbled with 95% O 2 and 5% CO 2 . Briefly, adrenal glands were removed and placed into cold low-Ca 2+ solution composed of (in mM) 140 NaCl, 2 KCl, 26 NaHCO 3 , 10 glucose, 5 MgCl 2 , and 0.1 CaCl 2 , pH 7.4. The adrenal glands, after removal of surrounding fat tissue, were embedded in 3% low-melting agarose, sectioned at 70 µ m (Leica, VT1200S), and incubated at room temperature in solution containing (in mM) 140 NaCl, 2 KCl, 26 NaHCO 3 , 10 glucose, 2 MgCl 2 , and 2 CaCl 2 and adjusted to pH 7.4. After at least 1 h, slices were transferred to a recording chamber and imaged with a 60× objective and DIC optics (Olympus, BX51WI). Cells of the zona glomerulosa were identified by their rosette organization. Electrical signals were acquired at room temperature using a microelectrode amplifier (Multiclamp, 700B) and software (Clampex 10.3, Molecular Devices). As expected, cells when patched with a K + -based solution displayed spontaneous spiking that could be stimulated with Ang II. For measuring Cl -currents, patch pipettes were filled with solution containing (in mM) 117.5 CsMeSO 3 , 17.5 CsCl, 4 NaCl, 10 HEPES, 1 EGTA, and 1 MgCl 2 , adjusted to pH 7.3, while the bath solution contained (in mM) 117 NMDG-Cl, 23 NMDG-HCO 3 , 5 CsCl, 1.3 MgCl 2 , 9 glucose, and 2 CaCl 2 , adjusted to pH 7.3. Voltage steps from + 40 to − 120 mV from a holding potential of − 10 mV were used, with a final 1-s step at + 40 mV. Signals were digitized at 10 kHz, filtered at 2 kHz, and stored offline for analysis with Clampfit software 10.4.
For two-electrode voltage-clamp in Xenopus oocytes, human wild-type and Gly24Asp ClC-2 cRNAs were prepared from pFROG vectors (Ambion mMESSAGE mMACHINE T7 kit) and injected into Xenopus oocytes, at 13.8 ng and 9.2 ng per cell, respectively. Following 2 d of expression at 17 °C, two-electrode voltage-clamp was performed at room temperature using a TurboTEC amplifier (npi electronic) and pClamp software (Molecular Devices) to elicit ClC-2 currents (2-s steps from + 60 mV to -120 mV with a final 1-s step at + 40 mV) in ND109 solution containing (in mM) 109 NaCl, 2 KCl, 1 MgCl 2 , 1.8 CaCl 2 , and 2 HEPES and adjusted to pH 7.4. To test for the typical Cl -> I -selectivity of ClC channels, currents were sequentially measured in solutions containing 109 mM Cl -or 109 mM I -. To determine the pH sensitivity of currents, ND109 was buffered with 5 mM MES for pH 6.5 and with 5 mM Tris for pH 8.5. Offline analysis was performed with Clampfit software 10.4. Statistical significance was assessed using the Mann-Whitney test (Prism, GraphPad).
For patch-clamp analysis of transiently transfected H295R-S2 cells, cells were seeded at 30% confluence onto coverslips coated with poly-l-lysine (Sigma). Once adhered, they were transfected (X-fect) with bicistronic plasmids encoding emGFP (for identification of transfected cells) and, after an IRES sequence, ClC-2 WT or ClC-2
Asp24
. Cells were measured 12-24 h later. Both transiently and stably transfected cells were measured using a Multiclamp 700B amplifier (Axon Instruments), and gramicidin-perforated patch-clamp was performed so that the intracellular chloride concentration was not disturbed. The tips of patch pipettes were first filled with gramicidin-free internal pipette solution, containing (in mM) 100 KMeSO 3 , 30 KCl, 4 NaCl, 10 HEPES, 1 MgCl 2 , 1 EGTA, and 3 MgATP (pH 7.3; 280 mOsm/L), and then backfilled with the same solution containing 25 µ g/ml gramicidin. GFP-expressing cells were selected for analysis. Approximately 20 min following tight giga-seal formation, stable membrane potential measurements (I = 0 configuration) could be acquired with access resistances of < 100 MΩ in bath solution containing (in mM) 140 NaCl, 5 KCl, 10 HEPES, 1.8 MgCl 2 , and 1.8 CaCl 2 (pH 7.4; 300 mOsm/L). When adequate access resistance was attained (< 35 MΩ ), a Na + -and K + -free bath solution containing (in mM) 140 CsCl, 10 HEPES, 1.8 MgCl 2 , 1.8 CaCl 2 , and 20 sucrose (pH 7.3; 300 mOsm/L) was perfused to measure anion membrane currents in the voltageclamp configuration (1-s steps from 0 mV to -120 mV from a holding clamp of -10 mV). Measurements were performed at room temperature (22-24 °C) . Data are presented as means ± s.e.m.
Functional studies in H295R-S2 cells. The human adrenocortical carcinoma cell line H295R strain 2 (H295R-S2), kindly provided by W. E. Rainey (University of Michigan) 41 , was cultured in DMEM/Eagle's F12 medium (Gibco, Life Technologies) supplemented with 2% Ultroser G (PALL Life Sciences), 1% insulin/ transferrin/selenium premix (Gibco, Life Technologies), 10 mM HEPES (Gibco, Life Technologies), and 1% penicillin and streptomycin (Gibco, Life Technologies) and maintained in a 37 °C humidified atmosphere (5% CO 2 ).
For overexpression experiments, H295R-S2 cells were seeded into tissue culture dishes 100 in groups of 5,000,000 cells per dish and maintained in the conditions described. After 24 h, cells were resuspended in 100 μ l of Nucleofector R solution (AMAXA kit, Lonza) and transfected with 3 μ g of the ClC-2 WT or ClC-2 Asp24 pFROG construct or a GFP construct, using the electroporation program P-20.
To select only stably transfected cells, 48 h after transfection, cells were changed to medium containing 500 µ g/ml G418-genetycin (Gibco) and used after all GFPtransfected cells were dead. G418 selection was maintained during all functional studies. For aldosterone measurements and RNA extraction, cells were serum deprived in DMEM/F12 medium containing 0.1% Ultroser G for 24 h and then incubated for another 24 h with fresh medium containing 0.1% Ultroser G with no secretagogue or vehicle (basal), with the secretagogues Ang II (10 nM) or K + (12 mM), or with calcium channel blockers nifedipine (L-type calcium channel blocker, 10 µ M, Sigma) or mibefradil (T-type calcium channel blocker, 10 µ M, Sigma). At the end of the incubation time, supernatant and cells from each well were harvested for aldosterone measurement and RNA extraction. Three experiments using aldosterone secretagogues (n = 9) and two experiments using calcium channel blockers (n = 6) were independently conducted in triplicate. Human ClC-2-targeting (TRCN0000427876) and non-mammalian control (SHC002V) MISSION shRNA lentiviral transduction particles were obtained from Sigma-Aldrich. The shRNA sequences were inserted into the TRC2 pLKOpuro plasmid backbone. For lentiviral infections, the manufacturer's protocol was followed with slight modifications. 1 × 10 4 H295R-S2 cells were seeded in a 96-well plate. After 24 h, medium was changed and supplemented with 2 μ g/ml polybrene (Sigma). Lentiviral particles were then added at a multiplicity of infection of 10 and the medium was changed after overnight incubation. For selection, 2 μ g/ml puromycin (Gibco) was added to the medium. After two passages, cells were characterized in terms of mRNA expression and aldosterone production after incubation with or without secretagogue as mentioned above.
RNA extraction and RT-qPCR. Total RNA was extracted in TRIzol reagent (Ambion, Life Technologies) according to the manufacturer's recommendations. After DNase I treatment (Life Technologies), 500 ng of total RNA was reverse transcribed (iScript reverse transcriptase, Bio-Rad). Primers used for qPCR are described in Supplementary Table 3 . qPCR was performed using SYBR Green (Sso Advanced Universal SYBR Green Supermix, Bio-Rad) on a C1000 touch thermal cycler from Bio-Rad (CFX96 Real-Time System), according to the manufacturer's instructions. Controls without template were included to verify that fluorescence was not overestimated from primer-dimer formation or PCR contaminations. RT-qPCR products were analyzed in a postamplification fusion curve to ensure that a single amplicon was obtained. Normalization for RNA quantity and reverse transcriptase efficiency was performed against three reference genes (geometric mean of the expression of 18 S rRNA, HPRT1, and GAPDH), in accordance with the MIQE guidelines 42 . Quantification was performed using the standard curve method. Standard curves were generated using serial dilutions from a cDNA pool of all samples of each experiment, yielding a correlation coefficient of at least 0.98 in all experiments.
Aldosterone and protein assays. Aldosterone levels were measured in cell culture supernatants by ELISA. Antibody to aldosterone and aldosterone-3-CMO-biotin were kindly provided by C. Gomez-Sanchez 43 . Aldosterone concentrations were normalized to cell protein concentrations (determined using Bradford protein assays).
Statistical analyses.
Quantitative variables are reported as means ± s.e.m. when a Gaussian distribution was present or as medians and interquartile ranges when no Gaussian distribution was present. Pairwise comparisons were done with unpaired t tests and Mann-Whitney tests, respectively; multiple comparisons were done with the ANOVA test followed by a test for pairwise comparison of subgroups according to Bonferroni when a Gaussian distribution was present or Kruskal-Wallis followed by Dunn's test when no Gaussian distribution was present. Comparisons between two groups were performed with two-tailed t tests or two-tailed Mann-Whitney tests. A P value of < 0.05 was considered significant. For functional experiments, all results are expressed as means ± s.e.m. of three separate experiments performed in triplicate for ClC-2 overexpression studies with secretagogues, two separate experiments performed in triplicate for ClC-2 expression studies with calcium channel blockers, and two to four separate experiments performed in triplicate for ClC-2 knockdown studies. Analyses were performed using Prism5 (GraphPad).
URLs. Software used to analyze the whole-exome sequencing data, https://ihg4. helmholtz-muenchen.de/cgi-bin/mysql/snv-vcf/login.pl. 
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The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section) (2003)). This is contingent on the costs of shipment etc paid by the receiving lab, stating our help in the acknowledgement, and written assurance not to give the material out to others without our consent and not to use the material for commercial purposes. For mice, the receiving lab also has to give assurance that the animals will be kept and treated according to official regulations concerning animal welfare.
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
Rabbit polyclonal antibodies against a modified carboxy-terminal ClC-2 peptide were used for Western blots. They have been previously described in Hoegg-Beiler, M.B. et al. Disrupting MLC1 and GlialCAM and ClC-2 interactions in leukodystrophy entails glial chloride channel dysfunction. Nat Commun 5, 3475 (2014) . In that paper, their specificity was ascertained using tissue from our ClC-2 KO mice. Also in the present work, we have used adrenal glands from ClC-2 KO mice to ascertain their specificity (see Fig. 2a ). No commonly misidentified cell line was used.
Description of research animals
Provide details on animals and/or animal-derived materials used in the study.
We used WT and Clcn2-/-mice (Mus musculus, C57/Bl6 genetic background) to obtain tissue for analysis by Western blotting and electrophysiology. The Clcn2-/-mice have been described before (Bösl...Jentsch, EMBO J. (2001)). Adult mice of both sexes were used. In detail: For the Western blot shown in Fig. 2a , the brain tissue was from a 30 week-old male WT mice; the adrenal glands from a 58 weekold male WT mice and from a 56 week-old male ClC-2 KO mice.
For the electrophysiological analysis of chloride currents in zona glomerulosa cells. the following mice were used: WT: 2 males and 1 female, between 4 and 7 weeks of age; KO: 2 females, 6 and 10 weeks of age. Xenopus oocytes were taken from female Xenopus laevis frogs obtained from commercial suppliers by surgically removing the ovaries and isolating oocytes. These interventions and the keeping of Xenopus in our facility were according to German and European regulations and have been approved by the local authority (LAGeSo). The keeping of mice in the animal facility of the MDC and the method of sacrificing them for taking tissues also conformed to German and European laws and were approved by LAGeSo. These procedures are not legally considered as animal experiments.
Policy information about studies involving human research participants
Description of human research participants
Describe the covariate-relevant population characteristics of the human research participants.
All relevant information on human research participants has been provided in the manuscript.
